tiprankstipranks
Trending News
More News >
GMO Research & AI,Inc. (JP:3695)
:3695
Japanese Market
Advertisement

GMO Research & AI,Inc. (3695) AI Stock Analysis

Compare
0 Followers

Top Page

JP

GMO Research & AI,Inc.

(3695)

Rating:58Neutral
Price Target:
¥2,650.00
▲(9.73%Upside)
The overall stock score reflects concerns over high valuation and bearish technical indicators, despite strong financial stability. The high P/E ratio suggests potential overvaluation, and technical analysis points to a possible downtrend. The company's financial performance remains robust, but recent declines in revenue and net income are notable risks.

GMO Research & AI,Inc. (3695) vs. iShares MSCI Japan ETF (EWJ)

GMO Research & AI,Inc. Business Overview & Revenue Model

Company DescriptionGMO Research & AI, Inc. (3695) is a company specializing in providing market research solutions and artificial intelligence services. Operating within the technology and research sectors, the company focuses on delivering comprehensive data analysis, consumer insights, and AI-driven platforms to support businesses in making informed decisions. Their core offerings include online research panels, survey solutions, and AI-based analytics tools designed to optimize market strategies and enhance customer engagement.
How the Company Makes MoneyGMO Research & AI, Inc. generates revenue primarily through its market research services and AI solutions. The company offers subscription-based services for access to its online research panels and survey platforms, enabling clients to conduct targeted market research efficiently. Additionally, the firm provides customized AI analytics tools that businesses utilize to analyze consumer behavior, predict trends, and improve operational efficiency. These services are often delivered through long-term contracts and partnerships with various companies across different industries. By leveraging its proprietary technology and data assets, GMO Research & AI, Inc. secures a steady income stream while also expanding its client base through strategic collaborations and service offerings.

GMO Research & AI,Inc. Financial Statement Overview

Summary
GMO Research & AI, Inc. demonstrates solid financial health with strong balance sheet metrics and consistent operational efficiency. Nonetheless, recent declines in revenue and net income signal potential challenges ahead. While the company manages its debt well, improving cash flow generation and sustaining revenue growth are crucial for future success.
Income Statement
62
Positive
The company's revenue has shown volatility, with a decline from 2023 to 2024. Although gross profit margins have remained stable around 50%, the net profit margin has decreased from 2023 to 2024, indicating potential challenges in cost management. Stability in EBIT and EBITDA margins suggests operational efficiency but the recent decline in net income is a concern.
Balance Sheet
75
Positive
The company exhibits strong financial stability with a low debt-to-equity ratio, suggesting prudent leverage management. The equity ratio is healthy, indicating a strong capital base. However, the return on equity has weakened from 2023 to 2024, reflecting reduced profitability from shareholders' equity.
Cash Flow
68
Positive
The cash flow position is relatively stable, with positive free cash flow and a reasonable operating cash flow to net income ratio. However, the decline in free cash flow from 2023 to 2024 raises concerns about future cash generation capabilities. The company maintains a strong liquidity position.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.03B5.12B5.20B4.09B3.39B
Gross Profit2.55B2.54B2.46B1.98B1.59B
EBITDA354.23M518.18M544.66M454.54M311.69M
Net Income183.15M307.31M356.38M274.06M175.67M
Balance Sheet
Total Assets3.00B2.99B3.07B2.80B2.23B
Cash, Cash Equivalents and Short-Term Investments1.19B1.33B767.04M664.93M663.18M
Total Debt5.50M12.22M16.80M19.29M12.33M
Total Liabilities883.41M946.14M1.16B1.12B748.50M
Stockholders Equity2.10B2.05B1.91B1.68B1.48B
Cash Flow
Free Cash Flow236.00M354.53M39.82M406.93M268.05M
Operating Cash Flow237.50M475.49M131.65M482.16M363.00M
Investing Cash Flow-221.00M-131.49M-111.34M-50.65M-95.03M
Financing Cash Flow-195.90M-187.50M-145.31M-96.53M-82.56M

GMO Research & AI,Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2415.00
Price Trends
50DMA
2504.50
Positive
100DMA
2675.94
Negative
200DMA
2578.44
Negative
Market Momentum
MACD
-19.90
Negative
RSI
55.53
Neutral
STOCH
58.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3695, the sentiment is Positive. The current price of 2415 is below the 20-day moving average (MA) of 2484.40, below the 50-day MA of 2504.50, and below the 200-day MA of 2578.44, indicating a neutral trend. The MACD of -19.90 indicates Negative momentum. The RSI at 55.53 is Neutral, neither overbought nor oversold. The STOCH value of 58.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3695.

GMO Research & AI,Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
¥8.04B11.90
7.11%1.91%
70
Outperform
¥16.01B77.06
4.98%-192.51%
69
Neutral
¥11.26B21.04
52.86%1255.76%
66
Neutral
¥28.11B23.84
0.14%-21.25%
63
Neutral
$34.27B4.89-11.70%1.94%5.41%-20.02%
63
Neutral
¥4.66B
1.01%-15.90%-388.21%
58
Neutral
¥10.57B165.18
4.78%-1.38%-91.00%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3695
GMO Research & AI,Inc.
2,548.00
-186.07
-6.81%
JP:3633
GMO Pepabo, Inc.
1,530.00
62.63
4.27%
JP:3680
Hotto Link, Inc.
297.00
-102.97
-25.74%
JP:3694
OPTiM Corp.
508.00
-159.00
-23.84%
JP:4488
AI inside, Inc.
4,110.00
-600.00
-12.74%
JP:5582
GRID Inc.
2,370.00
265.00
12.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 23, 2025